180
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Albendazole solution formulation via vesicle-to-micelle transition of phospholipid-surfactant aggregates

ORCID Icon, , & ORCID Icon
Pages 1130-1138 | Received 10 Nov 2017, Accepted 05 Feb 2018, Published online: 20 Feb 2018

References

  • Pourgholami MH, Woon L, Almajd R, et al. In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole. Cancer Lett. 2001;165:43–49.
  • Morris DL, Jourdan JL, Pourgholami MH. Pilot study of albendazole in patients with advanced malignancy. Effect on serum tumor markers/high incidence of neutropenia. Oncology. 2001;61:42–46.
  • Yalkowsky AH, He Y, Jain P. Handbook of aqueous solubility data. 2nd ed. Boca Raton (FL): CRC Press, Taylor & Francis Group; 2010.
  • Torrado S, Torrado S, Cadórniga R, et al. Formulation parameters of albendazole solution. Int J Pharm. 1996;140:45–50.
  • Torrado S, López ML, Torrado G, et al. A novel formulation of albendazole solution: oral bioavailability and efficacy evaluation. Int J Pharm. 1997;156:181–187.
  • Rigter IM, Schipper HG, Koopmans RP, et al. Relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with healthy volunteers. Antimicrob Agents Chemother. 2004;48:1051–1054.
  • Meena AK, Sharma K, Kandaswamy M, et al. Formulation development of an albendazole self-emulsifying drug delivery system (SEDDS) with enhanced systemic exposure. Acta Pharm. 2012;62:563–580.
  • Mukherjee T, Plakogiannis FM. Development and oral bioavailability assessment of a supersaturated self-microemulsifying drug delivery system (SMEDDS) of albendazole. J Pharm Pharmacol. 2010;62:1112–1120.
  • El-Badry M, Fetih G, Salem-Bekhet M, et al. Formulation and evaluation of nanosuspension of albendazole for dissolution enhancement. Nanosci Nanotechnol Lett. 2013;5:1024–1029.
  • Wen H, New RRC, Muhmut N, et al. Pharmacology and efficacy of liposome-entrapped albendazole in experimental secondary alveolar echinococcosis and effect of co-administration with cimetidine. Parasitology. 1996;113:111–121.
  • Li H, Song T, Qin Y, et al. Efficiency of liposomal albendazole for the treatment of the patients with complex alveolar echinococcosis: a comparative analysis of CEUS, CT, and PET/CT. Parasitol Res. 2015;114:4175–4180.
  • Panwar P, Pandey B, Lakhera PC, et al. Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes. Int J Nanomedicine. 2010;5:101–108.
  • Rodrigues JM, Bories C, Emery I, et al. Development of an injectable formulation of albendazole and in vivo evaluation of its efficacy against Echinococcus multilocularis metacestode. Int J Parasitol. 1995;25:1437–1441.
  • Noorani L, Stenzel M, Liang R, et al. Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model. J Nanobiotechnol. 2015;13:25–37.
  • Liu Y, Wang X-Q, Ren W-X, et al. Novel albendazole-chitosan nanoparticles for intestinal absorption enhancement and hepatic targeting improvement in rats. J Biomed Mater Res Part B Appl Biomater. 2013;101:998–1005.
  • Abulaihaiti M, Wu X-W, Qiao L, et al. Efficacy of albendazole-chitosan microsphere-based treatment for alveolar echinococcosis in mice. PLoS Negl Trop Dis. 2015;9:e0003950. doi:10.1371/journal.pntd.0003950
  • Kang BS, Lee SE, Ng CL, et al. Exploring the preparation of albendazole-loaded chitosan-tripolyphosphate nanoparticles. Materials. 2015;8:486–498.
  • Evrard B, Chiap P, DeTullio P, et al. Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-β-cyclodextrin. J Control Release. 2002;85:45–50.
  • García JJ, Bolás F, Torrado JJ. Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole. Int J Pharm. 2003;250:351–358.
  • Zhao Y, Buck DP, Morris DL, et al. Solubilisation and cytotoxicity of albendazole encapsulated in cucurbit[n]uril. Org Biomol Chem. 2008;6:4509–4515.
  • Ma D, Hettiarachchi G, Nguyen D, et al. Acyclic cucurbit[n]uril molecular containers enhance the solubility and bioactivity of poorly soluble pharmaceuticals. Nat Chem. 2012;4:503–510.
  • Hettiarachchi G, Samanta SK, Falcinelli S, et al. Acyclic cucurbit[n]uril-type molecular container enables systemic delivery of effective doses of albendazole for treatment of SK-OV-3 xenograft tumors. Mol Pharmaceutics. 2016;13:809–818.
  • Del Estal JL, Alvarez AI, Villaverde C, et al. Effect of surfactants on albendazole absorption. J Pharm Biomed Anal. 1991;9:1161–1164.
  • Del Estal JL, Alvarez AI, Villaverde C, et al. Comparative effects of anionic, natural bile acid surfactants and mixed micelles on the intestinal adsorption of the anthelmintic albendazole. Int J Pharm. 1993;91:105–109.
  • Del Estal JL, Alvarez AI, Villaverde C, et al. Increased systematic bioavailability of albendazol when administered with surfactants in rat. Int J Pharm. 1994;102:257–260.
  • Redondo PA, Alvarez AI, García JL, et al. Influence of surfactants on oral bioavailability of albendazole based on the formation of the sulphoxide metabolites in rats. Biopharm Drug Dispos. 1998;19:65–70.
  • Li P, Vishnuvajjala R, Tabibi CE, et al. Evaluation of in vitro precipitation methods. J Pharm Sci. 1998;87:196–199.
  • Wians FH. Blood tests: normal values. In: Merck manual, Professional edition. Kenilworth (NJ): Merck & Co., Inc.; [cited 2017 Aug 10]. Available from http://www.merckmanuals.com/professional/appendixes/normal-laboratory-values/blood-tests-normal-values#v8508814
  • Rangel-Yagui CO, Pessoa JA, Tavares LC. Micellar solubilization of drugs. J Pharm Pharm Sci. 2005;8:147–163.
  • FDA Inactive Ingredients Database. FDA/Center for Drug Evaluation and Research. Database Last Updated: July 5, 2017; [cited 2017 Aug 17]. Available from: https://www.accessdata.fda.gov/scripts/cder/iig/
  • Shi Y, Porter W, Merdan T, et al. Recent advances in intravenous delivery of poorly water-soluble compounds. Expert Opin Drug Deliv. 2009;6:1261–1282.
  • Patel K, Forbes B, Cram M. A Study into upper and lower pH limits of intravenous products delivered by infusion. London: King's College London; 2013; [cited 2017 July 10]. Available from: https://www.kcl.ac.uk/lsm/research/divisions/ips/Documents/News/2013/April/KooshPatel.pdf
  • Stoyanova K, Vinarov Z, Tcholakova S. Improving ibuprofen solubility by surfactant-facilitated self-assembly into mixed micelles. J Drug Deliv Sci Technol. 2016;36:208–215.
  • Stephenson BC, Rangel-Yagui CO, Pessoa A, et al. Experimental and theoretical investigation of the micellar-assisted solubilization of ibuprofen in aqueous media. Langmuir. 2006;22:1514–1525.
  • Hosseinzadeh R, Gheshlagi M, Tahmasebi R, et al. Spectrophotometric study of interaction and solubilization of procaine hydrochloride in micellar systems. Centr Eur J Chem. 2009;7:90–95.
  • Park SH, Choi HK. The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs. Int J Pharm. 2006;321:35–41.
  • Caetano W, Gelamo EL, Tabak M, et al. Chlorpromazine and sodium dodecyl sulfate mixed micelles investigated by small angle X-ray scattering. J Colloid Interface Sci. 2002;248:149–157.
  • Caetano W, Barbosa LRS, Itri R, et al. Trifluoperazine effects on anionic and zwitterionic micelles: a study by small angle X-ray scattering. J Colloid Interface Sci. 2003;260:414–422.
  • Reis S, Moutinho CG, Pereira E, et al. Beta-blockers and benzodiazepines location in SDS and bile salt micellar systems. An ESR study. J Pharm Biomed Anal. 2007;45:62–69.
  • Maity B, Chatterjee A, Ahmed SA, et al. Interaction of the nonsteroidal anti-inflammatory drug indomethacin with micelles and its release. J Phys Chem B. 2015;119:3776–3785.
  • Tokiwa F. Micellar properties of a series of sodium dodecylpolyoxyethylene sulfates from hydrodynamic data. J Phys Chem. 1967;71:1343–1348.
  • Vinarov Z, Katev V, Radeva D, et al. Micellar solubilization of poorly water-soluble drugs: effect of surfactant and solubilizate molecular structure. Drug Dev Ind Pharm. 2018;44:677–686.
  • Bhat PA, Dar AA, Rather GM. Solubilization capabilities of some cationic, anionic, and nonionic surfactants toward the poorly water-soluble antibiotic drug erythromycin. J Chem Eng Data. 2008;53:1271–1277.
  • Ong JTH, Manoukian E. Micellar solubilization of timobesone acetate in aqueous and aqueous propylene glycol solutions of nonionic surfactants. Pharm Res. 1988;5:704–708.
  • Krishna AK, Flanagan DR. Micellar solubilization of a new antimalarial drug, beta-arteether. J Pharm Sci. 1989;78:574–576.
  • Ullah I, Baloch MK, Ullah I, et al. Enhancement in aqueous solubility of Mefenamic acid using micellar solutions of various surfactants. J Solut Chem. 2014;43:1360–1373.
  • Klevens HB. Solubilization. Chem Rev. 1950;47:1–74.
  • Tah B, Pal P, Mishra S, et al. Interaction of insulin with anionic phospholipid (DPPG) vesicles. Phys Chem Chem Phys. 2014;16:21657–21663.
  • Fan Y, Li Y, Yuan G, et al. Comparative studies on the micellization of sodium bis(4-phenylbutyl) sulfosuccinate and sodium bis(2-ethylhexyl) sulfosuccinate and their interaction with hydrophobically modified poly(acrylamide). Langmuir. 2005;21:3814–3820.
  • Israelachvili JN, Mitchell DJ, Ninham BW. Theory of self-assembly of hydrocarbon amphiphiles into micelles and bilayers. J Chem Soc, Faraday Trans. 1976;72:1525–1568.
  • Fattal DR, Andelman D, Ben-Shaul A. The vesicle-micelle transition in mixed lipid-surfactant systems: a molecular model. Langmuir. 1995;11:1154–1161.
  • Albayrak R, Yuksel S, Colbay M, et al. Hemodynamic changes in the cephalic vein of patients with hemodialysis arteriovenous fistula. J Clin Ultrasound. 2007;35:133–137. doi:10.1002/jcu.20307
  • Salager JL, Marquez N, Gracia A, et al. Partitioning of ethoxylated octylphenol surfactants in microemulsion − oil − water systems: influence of temperature and relation between partitioning coefficient and physicochemical formulation. Langmuir. 2000;16:5534–5539.
  • Torrealba V, Johns RT. Coupled interfacial tension and phase behavior model based on micellar curvatures. Langmuir. 2017;33:13604–13614.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.